6161 - 6170 of 8801 Results
Title
Year
-
RESTRICTEDTitle: Special focus section: Gene therapy for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 209Issue #: 1Start Page: 28End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2007.09.006Citation Count: 6
-
RESTRICTEDTitle: Concerns with the new biological research criteria for synucleinopathy – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 7Start Page: 663End Page: 666Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00233-3Citation Count: 3
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
-
OPENTitle: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European populationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00896-2Best OA location URL: https://www.nature.com/articles/s41531-025-00896-2.pdfCitation Count: 0
-
OPENTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2889226Citation Count: 14
-
OPENTitle: Money without collaboration won't bring curesJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 19Issue #: 2Start Page: 127End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nm0213-127Best OA location URL: https://www.nature.com/articles/nm0213-127.pdfCitation Count: 4
-
OPENTitle: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1216End Page: 1228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28472Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28472Citation Count: 67
-
OPENTitle: A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related DisordersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1105End Page: 1114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230257Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230257?id=journal-of-parkinsons-disease%2Fjpd230257Citation Count: 4
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/111216027/The_role_of_phosphodiesterase_WILSON_Accepted18February2019_GREEN_AAM.pdfCitation Count: 15
-
OPENTitle: An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf159Best OA location URL: https://doi.org/10.1093/braincomms/fcaf159Citation Count: 0